ReleaseWire Connect

Net Bags Market: Global industry segment analysis, regional outlook, share, growth; Net Bags Market 2017 to 2027 by future market insights

Tube packaging is gaining traction among packaging manufacturers catering to cosmetics and oral care applications. Aluminum material possesses unique properties like lightweight, easy molding, anti-corrosive, etc. which makes it a better choice for packaging. This has encouraged manufacturers to opt for aluminum tubes over other alternatives. One of the most prominent property of aluminum tubes is that it remains neutral or inactive when mixed with other products. Along with effective material properties, aluminum tubes offer protection over longer duration of time. Collapsible aluminum tubes have emerged as one of the most innovative packaging products offered in the global market for aluminum tubes.

Infectious disease diagnostics is process of identifying the presence of foreign antigen/organism with the help of various diagnostic tools. Infectious disease conditions are highly prevalent in under developed regions due to lack of awareness for personal hygiene, minimal healthcare expenditures and absence of efficient physician services. The high incidence of infectious diseases across emerging economies formulate a major share in overall market. This has grab the attention of in vitro diagnostic device manufactures to invest into emerging economies. These companies are taking efforts to develop and commercialize cost effective tools for the infectious disease diagnosis. Presently, the gold standard tests available for bacterial infections and sexually transmitted disease diagnosis have major market share. However, these test are expected to replace by molecular techniques in future.

Diabetes mellitus is one of the most widely prevalent endocrine disorder of carbohydrate metabolism. Over the last couple of years, there has been a significant rise in diabetes mellitus cases worldwide. Sedentary lifestyle coupled with unhealthy dietaries leads to obesity which in turn is fueling diabetic cases. Glucose sensors is a compact analytical device or a unit incorporating a biological or biologically derived sensitive recognition element integrated with physiochemical transducer. Self-monitoring blood glucose investigated in diabetes mellitus is essential for insulin treatment or oral glucose lowering medication to provide information of glucose concentrations in our body. These sensors has proved quite efficient in monitoring the glucose level in human body, thus gaining wide popularity among healthcare practitioners for assessment purpose.

Drug delivery system is the process of administering therapeutic substance through common route of administration to achieve a therapeutic effect in humans or animals. Drugs release the active ingredients in the target area so that in the period of time it controls though its formulation. The most important driving factor for drug delivery technology market is the increasing demand for effective delivery mechanisms of novel biopharmaceuticals.

Future Market Insights' recent report on the reprocessed medical devices market in Asia-Pacific region projects that in 2017 and beyond, Japan, China and Southeast Asia will collectively account for more than 60% share of overall market revenues. The report estimates that reprocessed medical devices market in Asia-Pacific is presently valued at US$ 236.9 Mn. In a ten-year forecast period, the market is being projected to expand at 15.7% CAGR and bring in a little over US$ 1 Bn by the end of 2027.

Obese people are seldom prone to health implications arising from increasing caseload for varicose veins in their body. The rising number of obesity cases recorded across the globe are prompting the adoption of endovenous laser therapy for treatment of varicose veins. A latest study on global endovenous laser therapy market, published by Future Market Insights, indicates that growing attention towards aftereffects of lifestyle choices and consequences of obesity have collectively factored the growth in demand for endovenous laser therapies. With the help of this minimally-invasive therapy, which is guided by ultrasound laser techniques, vascular surgeons and radiologists can effectively treat impaired varicose vessels and curb the occurrence of side effects such as temporary paraesthesia.

In a recent report published by Future Market Insights, the global radiopharmaceuticals revenues in 2016 reached an estimated US$ 4,800 million value, and are anticipated to close in on US$ 8,500 million by the end of 2026. In terms of revenue, the global radiopharmaceuticals market is projected to soar steadily at 5.9% CAGR.

According to the latest market report published by Future Market Insights titled 'Breast Pump Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)', the global breast pumps market is expected to expand at a CAGR of 4.6% during the forecast period 2017–2027. Future Market Insights delivers key insights and presents a revised forecast of the global breast pump market for a 10 year period from 2017 to 2027. The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving factors, as well as the recent developments of key market participants. The increasing women workforce, along with raising awareness about human milk banks and temporary breastfeeding difficulties such as engorgement, poor attachment, breast refusal, nipple soreness etc. are the main factors which are also expected to bolster the growth of the global breast pump market.

Growing number of diabetics in the US, Canada and European countries has been compelling hospitals to keep artificial pancreas systems in stock. Government-funded organisations in North America and Europe are collaborating with local as well as global medical device manufacturers to meet the rising demand for artificial pancreas systems. A latest report published by Future Market Insights reveals that the value of artificial pancreas systems market in North America and Europe reached US$ 86.5 Mn by the end of 2016. The report also predicts that people suffering from diabetes in these regions will keep opting for artificial pancreas systems in order to control their blood sugar levels externally.